期刊文献+

富马酸泰诺福韦酯的合成 被引量:9

Synthesis of Tenofovir Disoproxil Fumarate
原文传递
导出
摘要 腺嘌呤与(R)-环氧丙烷缩合得(R)-9-(2-羟基丙基)腺嘌呤,经醚化、水解得到泰诺福韦,再经氯甲基碳酸异丙酯酯化、成盐制得抗病毒药富马酸泰诺福韦酯,总收率约21%。 Tenofovir disoproxil fumarate was synthesized from adenine via ring-opening condensation with (R) -propylene oxide,etherification and hydrolysis to give tenofovir,which was subjected to reaction with chloromethyl isopropyl carbonate,followed by salt formation with an overall yield of about 21%.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2011年第2期81-83,共3页 Chinese Journal of Pharmaceuticals
关键词 富马酸泰诺福韦酯 抗病毒药 合成 tenofovir disoproxil fumarate antiviral drug synthesis
  • 相关文献

参考文献11

  • 1张久聪,聂青和.治疗慢性乙型肝炎新药-替诺福韦酯[J].世界华人消化杂志,2008,16(24):2679-2688. 被引量:23
  • 2顾飞军,刘燕刚.富马酸替诺福韦酯合成路线图解[J].中国医药工业杂志,2008,39(10):783-785. 被引量:9
  • 3Arimilli MN,Cundy KC,Dougherty JP,et al.Nucleotide analogs:WO,9804569[P].1998-02-05.(CA 1998,128:140970). 被引量:1
  • 4Joel T.Preparing optically active adenine hydroxypropylene comprises heating adenine with (R) -propylene oxide or (S)-propylene oxide in presence of solid base mineral and in organic solvent medium:FR,2884823[P].2006-10-27.(CA 2006,145:438458). 被引量:1
  • 5Schultze LM,Chapman HH,Dubree NJP,et al.Practicalsynthesis of the anti-HIV drug,PMPA[J].Tetrahedron Lett,1998,39(14):1853-1856. 被引量:1
  • 6Ortmann R,Wiesner J,Reichenberg A,et al.Alkoxycarbonyloxyethyl ester prodrugs of FR900098 with improved in vivo antimalarial activity[J].Arch Pharm Chem Life Sci,2005,338 (7):305-314. 被引量:1
  • 7Barral K,Priet S,Sire J,et al.Synthesis,in vitro antiviral evaluation,and stability studies of novel α-boranonucleotide analogues of 9-[2-(phosphonomethoxy) ethyl] adenine and (R) -9-[2-(phosphonomethoxy) propyl] adenine[J].JMed Chem,2006,49 (26):7799-7806. 被引量:1
  • 8Becker MW,Chapman HH,Cihlar T.Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same:WO,0208241[P].2002-01-31.(CA 2002,136:118705). 被引量:1
  • 9Holy A,Dvorakova H,Declercq EDA,et al.Antiretroviral enantiomeric nucleotide analogs:WO,9403467[P].1994-02-17.(CA 1994,122:106401). 被引量:1
  • 10Rao VUM,Prasad VSR,Babu BR,et al.An Improved process for the preparation of tenofovir:WO,2008007392[P].2007-07-11.(CA2008,148:168505). 被引量:1

二级参考文献120

共引文献30

同被引文献51

  • 1梁朝阳,刁伟,曹孝文.抗HIV感染药富马酸替诺富韦酯中两个杂质的合成[J].化工管理,2013(14):68-68. 被引量:1
  • 2崔岚,安富荣,王晓珉.核苷酸逆转录酶抑制剂替诺福韦DF[J].中国新药杂志,2004,13(11):1054-1058. 被引量:30
  • 3唐小平,童裕维.HBV/HIV合并感染的研究进展[J].内科急危重症杂志,2006,12(3):138-141. 被引量:3
  • 4吴顶,王志.新型R-碳酸丙烯酯合成装置:中国,201962427U[P].2011-08-24. 被引量:1
  • 5杨先贵,周喜,王公应.一种二氧化碳与环氧化物合成环状碳酸酯的方法:中国,专利:102190648[P],2011-09-12. 被引量:1
  • 6ARIMILLI M N, KIM C U, DOUGHERTY J, et al. Synthesis, in vitro biological evaluation and oral bioavailability of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) prodrugs[J]. Antiviral Chem Chemother, 1997, 8(6): 557-564. 被引量:1
  • 7FUNG H B, STONE E A, PIACENTI F J. Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection[J]. Clin Ther, 2002, 24(10):1515-1548. 被引量:1
  • 8JENH A M, PHAM P A. Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B[J]. Expert Rev Anti Infect Ther, 2010, 8(10):1079-1092. 被引量:1
  • 9FRIIS G J, BUNDGAARD H. Prodrugs of phosphates and phosphonates: novel lipophilic α-acyloxyalkyl ester derivatives of phosphate- or phosphonate containing drugs masking the negative charges of these groups[J]. Eur J Pharm Sci, 1996, 4(1):49-59. 被引量:1
  • 10JONES J, COLQUITT J, SHEPHERD J, et al. Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B infection[J]. Health Technol Assess, 2010, 14 (Suppl. 1):23-30. 被引量:1

引证文献9

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部